None

Ramipril helps reduce claudication

JAMA2013;309:453-60Few effective drug treatments are available for intermittent claudication, so a successful trial of ramipril has been given a cautious welcome by researchers from Australia. In a......

Ramipril Improves Walking For People With PAD

Pain-free walking as well as length of walk both improved greatly in patients with claudication following treatment with the ACE blocker ramipril. The new study, published in JAMA, revealed pain-free...

Ramipril Substantially Improved Walking Times in PAD Trial

After six months, patients with peripheral artery disease and intermittent claudication who were treated with ramipril were able to walk considerably longer pain free and walk much farther on a treadm...

Ramipril Improves Walking For People With Peripheral Artery Disease

Pain-free walking as well as length of walk both improved greatly in patients with claudication following treatment with the ACE blocker ramipril. The new study, published in JAMA, revealed pain-free...

Some PAD patients on ramipril walk for longer without pain

Treatment with ramipril is associated with increases in pain-free and maximum treadmill walking times compared with placebo in patients with peripheral artery disease (PAD), according to a study publ...

Hypertension Drug Ramipril Helps PAD Patients Walk

A hypertension management drug could be able to help mobilise patients with constricted limb arteries, according to research carried out in Australia. The results of a new study suggest that ramipril...

Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication A Randomized Controlled Trial Ramipril Among Patients With PAD and Claudication

ImportanceApproximately one-third of patients with peripheral artery disease experience intermittent claudication, with consequent loss of quality of life.ObjectiveTo determine the efficacy of ramipri...

Ramipril may improve pain-free walking among patients with PAD and intermittent claudication

Among patients with peripheral artery disease and intermittent claudication (pain in the calf that comes and goes, typically felt while walking), 24 weeks of treatment with the angiotensin-converting...

Effect of Ramipril Alone Compared to Ramipril with Eplerenone on Diabetic Nephropathy in Streptozocin-Induced Diabetic Rats.

Background/Aims: We studied the effect of the combined treatment with an angiotensin-converting enzyme (ACE) inhibitor (ramipril) and eplerenone compared with ramipril alone in streptozocin-induced di...

Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry.

A rapid and sensitive liquid chromatography tandem mass spectrometry method has been developed and validated for the simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma....

Differences between zofenopril and ramipril, two ACE inhibitors, on cough induced by citric acid in guinea pigs: role of bradykinin and PGE2.

Dry and persistent cough is one of the commonest side effects experienced by patients treated with angiotensin-converting enzyme (ACE) inhibitors for the therapy of hypertension and congestive heart f...

Development and validation of UPLC tandem mass spectrometry assay for separation of a phase II metabolite of ramipril using actual study samples and its application to a bioequivalence study.

In this paper, we present a validated UPLC-MS/MS assay for determination of ramipril and ramiprilat from human plasma samples. The assay is capable of isolating phase II metabolites (acylglucornides)...

Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: Comparative analysis with rosuvastatin alone by intravascular ultrasound.

We tested the effects of rosuvastatin combined with ramipril on atheroma volume and its mechanism in de novo, intermediate coronary artery disease.